Pricing Pressure, Payer Perspectives and Innovative Diagnostic Platforms
Posted 24th August 2018 by Jane Williams
We spoke to Alex Bastian about how he got started in precision medicine, where he sees it going and how he intends to use real world evidence to unlock the potential around personalised approaches to drug development:
Precision Medicine and Companion Diagnostics in Stroke Patients
Posted 11th April 2018 by Jane Williams
A stroke is a clinical condition that could benefit greatly from personalized medicine. Strokes remain a leading cause of mortality and morbidity in the United States, affecting over 800,000 adults annually, leaving many with a permanent disability. The current stroke population are approximately 195,000 recurrent strokes, which are often more severe, debilitating, and costly than first-time strokes.
Highlights From The 4th Global Precision Medicine & Biomarkers Leaders Summit
Posted 21st February 2018 by Jane Williams
With just 3 months to go until the Precision Medicine & Biomarkers Leaders Summit: USA, we have taken some time to reflect on the Euopean Precision Medicine & Biomarkers Leaders Summit that took place in Munich in September.
Precision Medicine: An open letter from Miro Venturi
Posted 17th July 2017 by Jane Williams
Dear Colleagues,
In recent times, we have seen advances in precision medicine lead to powerful discoveries and improved patient care. Liquid biopsies for example, now have the potential to be a real game-changer in cancer testing and could revolutionise cancer care.
Presidents, Rock Stars and Companion Diagnostics
Posted 17th February 2017 by Jane Williams
President Jimmy Carter announced last spring that he no longer needed treatments for the metastatic melanoma found in his brain – after treatment with pembrolizumab (Keytruda, Merck), his physicians could no longer detect the cancer.
Morphometric analysis of the vascular network in renal cancer
Posted 19th October 2016 by Jane Williams
We recently formed a working group at Cedars-Sinai Medical Center in Los Angeles that integrates the research areas of molecular pathology, computational biology and digital image analysis under one umbrella and in one location.